CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	3 Months Ended		9 Months Ended
	Aug. 31, 2011	Aug. 31, 2010	Aug. 31, 2011	Aug. 31, 2010
Revenue	$ 12,329	$ 12,330	$ 36,988	$ 86,533
Operating expenses
Selling, general and administrative	382,860	207,116	1,392,557	613,201
Research and development	204,906	81,962	441,348	215,392
Depreciation and amortization	68	474	1,018	4,152
Total operating expenses	587,834	289,552	1,834,923	832,745
Loss from operations	(575,505)	(277,222)	(1,797,935)	(746,212)
Other income (expense)
Grant revenue	73,715	0	303,102	0
Interest expense	(5,871)	(6,296)	(17,724)	(18,472)
Change in fair value of derivative liability	381,517	95,204	(175,803)	91,298
Interest income	617	0	1,477	0
Total other income (expense)	449,978	88,908	111,052	72,826
Net loss	(125,527)	(188,314)	(1,686,883)	(673,386)
Less net loss attributable to the noncontrolling interests	(19,052)	(27,639)	(89,182)	(67,391)
Net loss attributable to MultiCell Technologies, Inc.	(106,475)	(160,675)	(1,597,701)	(605,995)
Preferred stock dividends	0	(31,741)	0	(105,733)
Net loss attributable to common stockholders	$ (106,475)	$ (192,416)	$ (1,597,701)	$ (711,728)
Basic and Diluted Loss Per Common Share Attributable to Common Stockholders (in dollars per share)	$ (0.0001)	$ (0.0005)	$ (0.0024)	$ (0.0020)
Basic and Diluted Weighted-Average Common Shares Outstanding (in shares)	770,658,629	399,253,590	657,413,346	357,304,464